May 2 (Reuters) - The U.S. Food and Drug Administration
has accepted Novo Nordisk's marketing application for
the experimental once-daily oral version of its blockbuster
weight-loss drug Wegovy, the Danish drugmaker said on Friday.
(Reporting by Sriparna Roy in Bengaluru; Editing by Sriraj
Kalluvila)